Abstract
A chronic daily headache (CDH) disorder is a very different illness than the more common episodic headache. While the episodic headache patient must cope with the uncertainty of when and where the next attack will occur, the CDH patient is frequently faced with relentless pain. This chapter aims to answer several questions:
First, how do we define CDH and what is the burden, to the individual and society, of this disorder?
Three to four percent of the worldwide population suffers from a chronic daily headache disorder encompassing chronic migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Second, what do we know about the mechanism underlying the transformation from episodic headache to CDH? We review evidence suggesting an underlying genetic vulnerability and involvement of glutamate, calcitonin-related peptide, and serotonin pathways. Finally, what risk factors shift an episodic headache to a daily or near-daily headache? The impact of medication overuse, obesity, sleep disturbances, stress, depression, and menstrual-related migraines on headache progression is discussed.
Our hope is that a greater understanding of headache transformation will lead to novel treatment approaches. At the very least, an awareness of modifiable risk factors may empower patients and help prevent an episodic headache from transforming to a chronic daily headache disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34(1):1–7.
Srikiatkhachorn A, Govitrapong P, Limthavon C. Up-regulation of 5HT-2 serotonin receptor: a possible mechanism of transformed migraine. Headache. 1994;34:8–11.
Gallai V, Alberti A, Coppola F, Floridi A, Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia. 2003;23:166–74.
Cernuda-Morollón E, Ramon C, Vega J, MartÃnez-Camblor P, Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191–6.
Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009;49:412–8.
Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME. Frequency of headaches in children is influenced by headache status in the mother. Headache. 2010;50:973–80.
Meletiche D, Lofland J, Young W. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41:573–8.
Munakata J, Hazard E, Serrano D, Klingman D, Rupnow M, Tierce J, Reed M, Lipton R. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2009;49:498–508.
Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483–90.
Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication overuse headache: a randomized controlled open-label trial. Cephalalgia. 2017;333102417737779.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.
Thorland K, Sun-Edelstein C, Druyts E, Kanters S, Ebrahim S, Bhambri R. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17:107.
Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.
Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545–50.
Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.
DomÃnguez C, Vieites-Prado A, Pérez-Mato M, Sobrino T, RodrÃguez-Osorio X, López A, Campos F, MartÃnez F, Castillo J, Leira R. Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia. 2017;333102417731351.
Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, Loewenthal N, Ifergane G. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31(13):1336–42.
Sancisi E, Cevoli S, Vignatelli L, Nicodemo M, et al. Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache. 2010;50(9):1464–72.
Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904–10.
Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–83.
Johnson KG, Zimeba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache. 2013;53(2):333–43.
Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache. 2006;46(9):1344–63.
Penzien DB, Rains JC, Holroyd KA. Psychological assessment of the recurrent headache sufferer. In: Tollinson CD, Kunkel RS, editors. Headache: diagnosis and treatment. Baltimore, MD: Williams and Williams; 1993. p. 39–49.
D’Amico D, Libro G, Prudenzano MP, Peccarisi C, et al. Stress and chronic headache. J Headache Pain. 2000;1:S49–52.
Paykel ES, Prusoff BA. Scaling of life events. Arch Gen Psychiatry. 1971;25(4):340–7.
Silberstein S, Olesen J. Chronic migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 613–7.
Costa A, Smeraldi C, Tassorellia R, Grecoa G. Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats. Neurosci Lett. 2005;383:22–9.
Blanchard EB, Appelbaum KA, Radnitz CL, et al. The refractory headache patient—I: chronic, daily, high intensity headache. Behav Res Ther. 1989;27:403–10.
Holroyd KA, Malinoski PE, O’Donnell FJ, et al. Antidepressant medication and cognitive behavioral therapy for CTTH: predictors of treatment response and dose-response relationships. Headache. 2002;42:456–7.
Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. 2006;46:1377–86.
Lake AE. Screening and behavioral management: medication overuse headache—the complex case. Headache. 2008;48:26–31.
Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalgia. 2005;25(3):165–78.
Ashina S, Serrano D, Lipton RB Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. Depression and risk of transformation of episodic to chronic migraine. Headache Pain. 2012;13:615–24.
Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44:S4–5.
Rivat C, Becker C, Blugeot A, et al. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain. 2010;150:358–68.
Boudreau GP, Grosberg BM, McAllister PJ, Sheftell FD, Lipton RB, Buse DC. Open-label, multicenter study of the efficacy and outcome of onabotulinumtoxin-A treatment in patients with chronic migraine and comorbid depressive disorders. J Headache Pain. 2010;11:S50.
Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist. 2004;10:221–34.
Zhang M, Liu Y, Zhao M, Wenjing T, Xiaolin W, Zhao D, Shengyuan Y. Depression and anxiety behaviour in a rat model of chronic migraine. Headache Pain. 2017;18(1):27.
Somerville BW. The influence of progesterone and estradiol upon migraine. Headache. 1972;12(3):93–102.
MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Pace, A., Mueller, B. (2019). From Episodic to Chronic: A Discussion on Headache Transformation. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-91491-6_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91490-9
Online ISBN: 978-3-319-91491-6
eBook Packages: MedicineMedicine (R0)